Explore our latest news & presentations

Ailux Appoints Lloyd S. Miller, M.D., Ph.D., as Chief Medical Officer

Ailux Presents New Preclinical Data Supporting its Long-Acting IL-4Rα Antibody and Expanding its Bispecific Applications at EADV 2026

Ailux Presents Preclinical Data on AI-optimized, CD3-Masked CD19×BCMA T-Cell Engager at EULAR 2026

Ailux Appoints Maria Belvisi, Ph.D., as Chief Scientific Officer

Ailux Selected for Digital Oral and Poster Presentations at ECCO’26, Highlighting Potential for Novel IBD Treatment

Ailux Announces Strategic Collaboration with Lilly to Advance Bispecific Antibody Development

Ailux Announces Posters at American College of Rheumatology (ACR) Convergence 2025

Ailux Enters into a License Agreement with Janssen Biotech on Biologics AI Platform

UCB Partners with Ailux on Biologics AI Platform